Evolution of the Functional and Muscular State of Patients With Muscular Dystrophy 2A Belts (NCT06390566) | Clinical Trial Compass
Active — Not RecruitingNot Applicable
Evolution of the Functional and Muscular State of Patients With Muscular Dystrophy 2A Belts
France25 participantsStarted 2024-05-28
Plain-language summary
Limb girdle muscular dystrophies were originally defined as a postnatal progressive muscle disease, which begins and primarily affects the pelvic and scapular muscles.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Confirmed diagnosis of autosomal recessive LGMD2A (two pathogenic mutations in the calpain 3 gene)
* Ability to participate in the tests and examinations planned by the study (manual muscle tests, motor scales)
* Informed and having signed a consent form
* Affiliate to a social security scheme in France (beneficiary or entitled person).
Exclusion Criteria:
* Patient with another disease likely to significantly interfere with the interpretation of the natural history of LGMD2A
* Participant in a clinical trial with an investigational product within 3 months preceding inclusion
* Patient unable or unwilling to comply with protocol requirements
* Patient under guardianship, curatorship or legal protection
* Pregnant or breastfeeding woman
* Patient deprived of liberty
* Adult patient unable to express consent
* Refusal to participate
What they're measuring
1
Evaluation of the loss of strength of muscle groups in patients with LGMD2A